Home Industry Dr Reddy’s API facility in Hyderabad receives 7 USFDA observations following inspection
Industry

Dr Reddy’s API facility in Hyderabad receives 7 USFDA observations following inspection

by Editorial
written by Editorial 0 comments

Shares of Dr Reddy’s Laboratories Ltd ended at ₹1,213.45, up by ₹20.10, or 1.68% on the BSE.

You may also like

Siemens Q4 Results | Net profit jumps 45% beating forecast; dividend declared

Insolvency plea against Amazon Wholesale dismissed again

UltraTech Cement approves allotment of ₹1,000-crore NCDs with 7.22% interest rate

DPIIT signs MoU with WinZO to focus on training gaming professionals

Infosys to distribute up to 85% variable pay bonus for Q2 FY25, reports say

Dabur gets revised ₹320.6-crore GST demand; penalty dropped

Leave a Comment

Save my name, email, and website in this browser for the next time I comment.

Laest News

Reduce oil intake, fight obesity, PM Modi appeals again
Don’t reveal bills before introduction: J&K Speaker
‘Virat victory’: Political leaders hail Team India’s triumph over Pakistan in Champions Trophy 2025
Centre bans manufacture and export of 2 drugs ‘fuelling’ West Africa opioid crisis

About

We provide timely, accurate, and insightful business news that drives informed decision-making. Our expert coverage spans markets, trends, and strategies to keep you ahead of the curve.

  • 305, City Avenue, Wakad, PCMC, MH, India
  • Email: contact@thebusinesslines.com

About Links

Upcoming Events

© 2024 – All Rights Reserved. Kryzen Technologies Private Limited

Facebook Twitter Instagram Linkedin Youtube Email